EMBC
Embecta Corp
NASDAQ: EMBC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.90
-57.84% today
Updated 2026-05-05
Market cap
$547.78M
P/E ratio
3.92
P/S ratio
0.51x
EPS (TTM)
$2.36
Dividend yield
6.50%
52W range
$4 – $15
Volume
1.1M
Embecta Corp (EMBC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
12.90%
Operating margin
29.20%
ROE
0.00%
ROA
18.40%
Debt/equity
-2.32x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $1.11B | $432.00M | 70.87% | 45.27% | 38.95% |
| 2020 | $1.09B | $427.60M | 70.29% | 44.86% | 39.39% |
| 2021 | $1.17B | $414.80M | 68.67% | 42.23% | 35.61% |
| 2022 | $1.13B | $223.60M | 68.61% | 33.47% | 19.80% |
| 2023 | $1.12B | $70.40M | 66.91% | 20.49% | 6.28% |
| 2024 | $1.12B | $78.30M | 64.90% | 15.51% | 6.97% |
| 2025 | $1.08B | $95.40M | 62.89% | 30.48% | 8.83% |